Congestive heart failure associated with hypertensive severe systolic left ventricular dysfunction. Long-term clinical and functional evolution;Insuficiencia cardíaca debida a disfunción ventricular sistólica severa de origen hipertensivo. Evolución clínica y funcional a largo plazo

Revista Espanola de Cardiologia

Volumn 53, Issue 7, 2000, Pages 927-931

  Anguita, Manuel ^a   Castillo, Juan C ^a   Ramírez, Antonio ^a   Siles, Juan R ^a   Ojeda, Soledad ^a   Mesa, Dolores ^a   Franco, Manuel ^a   Vallés, Federico ^a  

^a NONE

Author keywords

Cardiomyopathy; Heart failure; Hypertension; Prognosis

Indexed keywords

AGED; ARTICLE; CHRONIC DISEASE; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; TIME;

AGED; CARDIOMYOPATHY, DILATED; CHRONIC DISEASE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENTRICULAR DYSFUNCTION; VENTRICULAR FUNCTION, LEFT;

EID: 0034223163     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(00)75177-3     Document Type: Article

References (15)

1. Garg R, Packer M, Pitt B,Yusuf S. Heart failure en the 1990s: evolution of a major public health problem in cardiovascular medicine. J Am Coll Cardiol 1993; 22 (Supl A): 3-5.
2. Bonneux L, Barendregt JJ, Meeter K, Bonsel GL, Van der Maas PJ. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994; 84: 20-28.
3. Ho KKL, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Heart Study. J Am Coll Cardiol 1993; 22 (Supl A): 6-13.
4. Vasan RS, Levy D. The progression from hypertension to heart failure: an overview of pathogenic mechanisms. En: Coats A, editor Controversies in the management of heart failure. Londres: Churchill Livingstone, 1997; 1-9.
5. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KKL. The progression from hypertension to congestive heart failure. JAMA 1996; 275: 1557-1562.
6. Moser M, Hebert PR. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials. J Am Coll Cardiol 1996; 27: 1214-1218.
7. Anguita M. Lecciones de los ensayos clínicos en la insuficiencia cardíaca congestiva. Rev Esp Cardiol 1995; 48: 699-709.
8. Gheorgiade M, Benatar D, Konstam MA, Stoukides CA, Bonow RO. Pharmacotherapy for systolic dysfunction. A review of randomized clinical trials. Am J Cardiol 1997; 80: 14H-27H.
9. Johnstone D, Limacher M, Rousseau M. Clinical characteristics of patients in studies of left ventricular dysfunction (SOLVD). Am J Cardiol 1992; 70: 894-900.
10. Bourassa MG, Gurne O, Bangdiwala SI. Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators. J Am Coll Cardiol 1993; 22 (Supl A): 14-19.
11. Pitt B, Segal R, Martínez FA, Meurers G, Cowley AJ, Thomas I et al, on behalf of the ELITE Study Investigators. Ramdomised trial of losartan versus captopril in patients over 65 with heart failure. Lancet 1997; 349: 747-52.
12. The NETWORK Investigators. Clinical outcome with enalapril in symptomatic chronic heart failure: a dose comparison. Eur Heart J 1998; 19: 481-489.
13. Cohn JN. Structural changes in cardiovascular disease. Am J Cardiol 1995; 76: 24E-37E.
14. Vallés F, Anguita M. Cardioprotección y cardiorreparación en la hipertensión arterial sistémica. Rev Esp Cardiol 1997; 50 (Supl 4): 49-52.
15. Motz W, Schartzkopff B, Vogt M. Hypertensive heart disease: cardioreparation by reversal of interstitial collagen in patients. Eur Heart J 1995; 16: 69C-73C.